We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Promega SABiosciences Agreement Enables the Most Sensitive Tools for Pathway Analysis

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Promega and SABiosciences will combine their offerings to provide sensitive tools for interrogating specific cellular pathways via transcription factor reporters.

Under the new agreement Promega recombinant firefly luciferase luc2 gene and a humanized Renilla luciferase (hRluc) gene- the ‘dual luciferases’- will serve as one key reporter system for SABiosciences pathway reporter assays under the Cignal™ moniker.

Cignal transcription reporters from SABiosciences offer the widest selection of pathway activity assays, featuring more than 40 pathway reporters available in both DNA construct and viral particle formats.

“We are pleased to include Promega’s recombinant firefly and humanized Renilla luciferases as reporters in our product lines. They provide the necessary levels of sensitivity for studying the effects of drugs or genetic perturbations on many interesting and biologically relevant cell types.” said Dave Martz, VP of Sales and Marketing at SABiosciences.

The Cignal products with Promega luciferase technology are currently available in tube and plate formats for multiple pathways of biological interest.